Cargando…
Therapeutic Treatment of Superoxide Dismutase 1 (G93A) Amyotrophic Lateral Sclerosis Model Mice with Medical Ozone Decelerates Trigeminal Motor Neuron Degeneration, Attenuates Microglial Proliferation, and Preserves Monocyte Levels in Mesenteric Lymph Nodes
Amyotrophic lateral sclerosis (ALS) is an incurable and lethal neurodegenerative disease in which progressive motor neuron loss and associated inflammation represent major pathology hallmarks. Both the prevention of neuronal loss and neuro-destructive inflammation are still unmet challenges. Medical...
Autores principales: | Bette, Michael, Cors, Eileen, Kresse, Carolin, Schütz, Burkhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950555/ https://www.ncbi.nlm.nih.gov/pubmed/35328829 http://dx.doi.org/10.3390/ijms23063403 |
Ejemplares similares
-
An Allosteric
Pathway in Copper, Zinc Superoxide Dismutase
Unravels the Molecular Mechanism of the G93A Amyotrophic Lateral Sclerosis-Linked
Mutation
por: Souza, Paulo C. T., et al.
Publicado: (2019) -
Autophagic induction of amyotrophic lateral sclerosis-linked Cu/Zn superoxide dismutase 1 G93A mutant in NSC34 cells
por: Wei, Yanming
Publicado: (2014) -
The landscape of cognitive impairment in superoxide dismutase 1-amyotrophic lateral sclerosis
por: Martinelli, Ilaria, et al.
Publicado: (2022) -
Superoxide Dismutases
and Superoxide Reductases
por: Sheng, Yuewei, et al.
Publicado: (2014) -
Superoxide Dismutase Activity in Small Mesenteric Arteries Is Downregulated by Angiotensin II but Not by Hypertension
por: Kang, Kyu-Tae, et al.
Publicado: (2018)